DE20209391U1 - Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base - Google Patents

Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base

Info

Publication number
DE20209391U1
DE20209391U1 DE20209391U DE20209391U DE20209391U1 DE 20209391 U1 DE20209391 U1 DE 20209391U1 DE 20209391 U DE20209391 U DE 20209391U DE 20209391 U DE20209391 U DE 20209391U DE 20209391 U1 DE20209391 U1 DE 20209391U1
Authority
DE
Germany
Prior art keywords
ointment
oil
stressed
sea buckthorn
fragrance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20209391U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE20203549U priority Critical patent/DE20203549U1/en
Priority claimed from DE20203549U external-priority patent/DE20203549U1/en
Publication of DE20209391U1 publication Critical patent/DE20209391U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Abstract

Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base. ACTIVITY : Vulnerary; Antiulcer; Antiinflammatory; Dermatological. No biological data given. MECHANISM OF ACTION : None given.

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßtThe description text was not recorded electronically

Claims (8)

1. Salbe zur Behandlung von trockener, stark beanspruchter bzw. wunder Haut ist dadurch gekennzeichnet, dass die Salbe einen Anteil Ol. Olivarum, einen Anteil Ol. Hippophae rhamnoides, einen öligen Geruchsstoff und einen Salbengrundstoff aufweist.1. Ointment for the treatment of dry, stressed or sore skin is characterized in that the ointment has a portion of Ol. Olivarum, a portion of Ol. Hippophae rhamnoides, an oily fragrance and an ointment base. 2. Salbe nach Anspruch 1, dadurch gekennzeichnet, dass der Anteil Ol. Olivarum etwa 6,6 Gewichtsprozent der Salbe beträgt.2. Ointment according to claim 1, characterized in that the proportion Ol. Olivarum is about 6.6 percent by weight of the ointment. 3. Salbe nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass der Anteil Ol. Hippophae rhamnoides 4,1 Gewichtsprozent der Salbe beträgt.3. Ointment according to claim 1 or 2, characterized in that the Proportion of Ol. Hippophae rhamnoides 4.1 percent by weight of the ointment is. 4. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass sie einen öligen Geruchsstoff aufweist.4. Ointment according to one of the preceding claims, characterized indicates that it has an oily odorant. 5. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, daß der ölige Geruchsstoff Ol. Citri beinhaltet. 5. Ointment according to one of the preceding claims, characterized records that the oily fragrance contains Ol. Citri.   6. Salbe nach Anspruch 5, dadurch gekennzeichnet, dass der Anteil Ol. Citri 6 gtt. der Salbe beträgt.6. Ointment according to claim 5, characterized in that the proportion Ol. Citri 6 gtt. the ointment is. 7. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass der Salbengrundstoff Eucerin cum aqua und Eucerin anhydricum aufweist.7. Ointment according to one of the preceding claims, characterized records that the ointment base Eucerin cum aqua and Eucerin has anhydricum. 8. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass die Salbe folgende Zusammensetzung aufweist:
6,6 Gewichtsprozent Ol. Olivarum, 4,1 Gewichtsprozent Ol. Hippophae rhamnoides, 6 gtt. Ol. Citri und etwa 89,3 Gewichts­ prozent Eucerin cum aqua sowie Eucerin anhydricum zu gleichen Teilen.8. Ointment according to one of the preceding claims, characterized in that the ointment has the following composition:
6.6% by weight Ol. Olivarum, 4.1% by weight Ol. Hippophae rhamnoides, 6 gtt. Ol. Citri and about 89.3 weight percent Eucerin cum aqua and Eucerin anhydricum in equal parts.
DE20209391U 2002-03-05 2002-03-05 Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base Expired - Lifetime DE20209391U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20203549U DE20203549U1 (en) 2002-03-05 2002-03-05 Care and healing ointment for the treatment of dry or inflamed nasal mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20203549U DE20203549U1 (en) 2002-03-05 2002-03-05 Care and healing ointment for the treatment of dry or inflamed nasal mucosa

Publications (1)

Publication Number Publication Date
DE20209391U1 true DE20209391U1 (en) 2003-04-30

Family

ID=7968630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20209391U Expired - Lifetime DE20209391U1 (en) 2002-03-05 2002-03-05 Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base

Country Status (1)

Country Link
DE (1) DE20209391U1 (en)

Similar Documents

Publication Publication Date Title
ATE214933T1 (en) DERMATOLOGICAL COMPOSITIONS CONTAINING BENZYLENE OXIDE AND A SKIN IRRITATION REDUCING AGENT
PE20001032A1 (en) COMPOSITIONS AND METHODS TO TREAT PULMONARY DISEASES
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
FR2777183B1 (en) USE OF AT LEAST ONE HYDROXYSTILBENE IN A COMPOSITION FOR PROMOTING DEQUAMATION OF THE SKIN AND COMPOSITION COMPRISING SAME
CA2158475A1 (en) Composition and method for reducing toxicity of biologically-active factors
ATE127691T1 (en) USE OF VITAMIN D ANALOGUE TO TREAT ACNE.
DE69910560D1 (en) WATER-SOLUBLE PRODRUGS OF 2,6-DIISOPROPYLPHENOL ANALOG
SI1545587T1 (en) Lactoferrin compositions and methods of diabetic ulcer treatment
EP1639991A3 (en) Skin and tissue care and/or treatment composition
DE60026152D1 (en) USE OF STEARIDONIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OR PREVENTION OF CANCER
DE69029100D1 (en) Use of ketoconazole and a retinoid to treat acne vulgaris
ATE435030T1 (en) HEALING OF WOUNDS OR FIBROTIC DISEASES USING AT LEAST ONE AGENT AGAINST ONE GROWTH FACTOR
DE68912195D1 (en) Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis.
ATE138567T1 (en) COMPOSITION AND METHOD FOR TREATING PAINFUL, INFLAMMATORY OR ALLERGIC DISEASES
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
ATE297722T1 (en) USE OF GABA ANALOGUE SUCH AS GABAPENTIN TO PRODUCE A MEDICATION FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE20209391U1 (en) Ointment for treating dry, stressed or wounded skin comprises olive oil, sea buckthorn oil, a fragrance oil and an ointment base
DE20218572U1 (en) Ointment for treating dry, stressed or wounded skin comprises olive oil, sea-buckthorn oil, nigella oil and a perfume oil
DE20209721U1 (en) Care ointment for the treatment of dry, heavily stressed and radiation-damaged skin
DE20301401U1 (en) Ointment for treating dry or damaged skin, comprises olive and cucumber oils and oily perfume, and has an antiinflammatory action
DE20300985U1 (en) Ointment for treating dry, stressed or damaged skin, containing synergistic combination of olive and Cucurbitae oils, Hippophae rhamnoides, odorant and ointment base
DE69804597T2 (en) OIL FOR TREATMENT OF BURNS AND OTHER SKIN DISEASES
ATE206052T1 (en) USE OF SPHINGOSINE-1-PHOSPHATE, SPHINGOSINE-1-PHOSPHATE DERIVATIVES AND/OR MIXTURES THEREOF FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
MX9801902A (en) Antiseptic skin care composition and method for making same.
DE20203549U1 (en) Care and healing ointment for the treatment of dry or inflamed nasal mucosa

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R207 Utility model specification

Effective date: 20030605

R156 Lapse of ip right after 3 years

Effective date: 20051001